Physician profile
Travis L Piester
NPI 1518251636
$14,893.27
in general payments reported to CMS, 2019-2025
12 companies · $589 in 2025
The $589 reported for 2025 was more than what 77% of Pediatric Gastroenterology providers received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.09 · 2020: $14.86 · 2021: $50.80 · 2022: $524 · 2023: $8,539 · 2024: $5,137 · 2025: $589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,648 · Travel and Lodging: $3,870 · Food and Beverage: $2,748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,648.00 |
| Travel and Lodging | $3,869.81 |
| Food and Beverage | $2,747.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $9,006.69 | 2022-2024 | System 2450, Conmed Biliary, Conmed Hemostasis |
| Boston Scientific Corporation | $3,232.43 | 2022-2025 | Apollo Esg Nxt System, Exalt Model D, Apollo Revise System |
| Olympus Corporation of The Americas | $1,612.34 | 2023-2025 | Disposable Distal Attachment, Olympus, Single Use Electrosurgical Knife Kd-655 |
| Olympus America INC. | $473.78 | 2022-2025 | Visiglide, Hanarostent Esophagus Tts(Ccc), Endoclot Phs |
| Cook Medical LLC | $200.74 | 2023 | Hemospray |
| Alcresta Therapeutics, INC. | $117.32 | 2024 | Relizorb |
| Abbvie INC. | $88.89 | 2019-2021 | |
| Medtronic, INC. | $51.53 | 2022-2024 | Endoflip |
| 3-D Matrix, INC. | $45.69 | 2024 | |
| Apollo Endosurgery US INC | $25.40 | 2022 | |
| Fujifilm Healthcare Americas Corporation | $23.60 | 2023 | Fujifilm |
| Qol Medical, LLC | $14.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Piester listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.